Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,456,830
+$26,318 QoQ
Shares Held
145,683
-3.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#103
of 316 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. BCRX ranks #22 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,284,773 | $130,058,261 | |
| 2 | VTRS |
Viatris Inc
|
3,165,469 | $50,267,647 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,105,005 | $37,437,568 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
185,545 | $31,271,754 | |
| 5 | ZTS |
Zoetis Inc.
|
237,394 | $17,059,132 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
188,565 | $12,058,731 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
690,897 | $11,959,425 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
98,305 | $10,905,956 |
All Filings in BCRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,456,830 | 145,683 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,430,512 | 150,264 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $804,623 | 103,157 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,749,218 | 362,216 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,000,256 | 223,243 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $821,002 | 109,467 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $430,068 | 57,190 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $422,962 | 55,653 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $258,614 | 41,847 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $214,538 | 42,232 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $234,579 | 39,162 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $269,081 | 38,006 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $190,044 | 26,995 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $362,823 | 43,504 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $831,266 | 72,410 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $329,905 | 26,183 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $311,220 | 29,416 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,278,897 | 78,653 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $494,832 | 35,728 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,151,510 | 80,133 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,877,231 | 118,737 | Shares | Defined | 2021-08-06 | |
| 2020-06-30 | $451,714 | 94,898 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||